Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 274

The DOI matches its Crossref record.

High‐dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double‐blind, placebo‐controlled, crossover study

Doorn, P.A. van, Brand, A., Strengers, P.F.W., Meulstee, J., Vermeulen, M.·1990·Neurology

Abstract

We discontinued high-dose intravenous immunoglobulin treatment (IVIg) in 7 patients with chronic inflammatory demyelinating polyneuropathy (CIDP) who seemed to have responded to IVIg. After discontinuation of treatment, all 7 patients deteriorated. We then randomized the patients to IVIg or placebo (albumin) treatment in a double-blind crossover study. The clinical condition of all patients improved after IVIg and did not improve after placebo treatment. The mean time lapse from the end of the trial treatment to the occurrence of deterioration was 6.4 weeks after treatment with IVIg and 1.3 weeks after treatment with placebo. This selected group of patients with CIDP had a beneficial response to IVIg.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.40.2.209

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 274

Metadata

Authors
Doorn, P. A. V., Brand, A., Strengers, P. F. W., Meulstee, J., & Vermeulen, M.
Venue
Neurology
Published
1990-02
Volume
40
Issue
2
Pages
209-209
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2127180052
Cited by
274
References
0
FWCI
12.80
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High‐dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double‐blind, placebo‐controlled, crossover study. https://app.cochat.ai/papers/10.1212/wnl.40.2.209
The paper
Doorn, P. A. V., Brand, A., Strengers, P. F. W., Meulstee, J., & Vermeulen, M. (1990). High‐dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double‐blind, placebo‐controlled, crossover study. Neurology. https://doi.org/10.1212/wnl.40.2.209

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.